OMN has been the subject of a number of other research reports. Zacks Investment Research upgraded OMNOVA Solutions from a sell rating to a hold rating in a report on Wednesday, February 14th. ValuEngine upgraded shares of OMNOVA Solutions from a hold rating to a buy rating in a research report on Wednesday, February 7th. One analyst has rated the stock with a sell rating and four have given a hold rating to the company. The stock currently has an average rating of Hold and an average price target of $11.50.
Shares of OMN traded up $0.20 during midday trading on Thursday, hitting $9.90. The stock had a trading volume of 91,200 shares, compared to its average volume of 139,086. The company has a debt-to-equity ratio of 6.66, a current ratio of 2.03 and a quick ratio of 1.31. The company has a market capitalization of $443.62 million, a price-to-earnings ratio of 17.32, a P/E/G ratio of 1.49 and a beta of 2.05. OMNOVA Solutions has a twelve month low of $8.10 and a twelve month high of $11.90.
OMNOVA Solutions (NYSE:OMN) last released its earnings results on Wednesday, March 28th. The specialty chemicals company reported $0.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.02. The business had revenue of $178.70 million for the quarter, compared to the consensus estimate of $174.65 million. OMNOVA Solutions had a positive return on equity of 32.70% and a negative net margin of 10.67%. OMNOVA Solutions’s quarterly revenue was up 2.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.05 earnings per share. sell-side analysts anticipate that OMNOVA Solutions will post 0.67 earnings per share for the current fiscal year.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. James Investment Research Inc. bought a new stake in OMNOVA Solutions during the fourth quarter valued at $1,072,000. First Quadrant L P CA bought a new position in shares of OMNOVA Solutions during the 4th quarter worth about $250,000. Cigna Investments Inc. New bought a new position in shares of OMNOVA Solutions during the 4th quarter worth about $239,000. Algert Global LLC boosted its position in shares of OMNOVA Solutions by 75.5% during the 4th quarter. Algert Global LLC now owns 156,183 shares of the specialty chemicals company’s stock worth $1,562,000 after purchasing an additional 67,212 shares in the last quarter. Finally, Teton Advisors Inc. boosted its position in shares of OMNOVA Solutions by 3.1% during the 4th quarter. Teton Advisors Inc. now owns 268,000 shares of the specialty chemicals company’s stock worth $2,680,000 after purchasing an additional 8,000 shares in the last quarter. Institutional investors and hedge funds own 90.46% of the company’s stock.
OMNOVA Solutions Company Profile
OMNOVA Solutions Inc provides emulsion polymers, specialty chemicals, and engineered surfaces for various commercial, industrial, and residential end uses in the United States, Europe, and Asia. The company operates in two segments, Specialty Solutions and Performance Materials. The Specialty Solutions segment designs, develops, produces, and markets specialty polymers which are used in various applications, such as architectural and industrial coatings; nonwovens used in hygiene products, filtration, and construction; drilling additives for oil and gas drilling, cementing, and fracking; elastomeric modification of plastic casings and hoses used in household, industrial products, and automobiles; tapes and adhesives; sports surfaces; textile finishes; commercial building refurbishment; new construction; residential cabinets; flooring; ceiling tiles; furnishings; manufactured housing; health care patient; common area furniture; and various industrial films applications.
Receive News & Ratings for OMNOVA Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OMNOVA Solutions and related companies with MarketBeat.com's FREE daily email newsletter.